Vipul Jairath1, J Thompson2, B C Kahan2, R Daniel3, S A Hearnshaw4, S P L Travis5, M F Murphy6, K R Palmer7, R F A Logan8. 1. 1] Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK [2] NHS Blood and Transplant Unit, John Radcliffe Hospital, Oxford,UK. 2. MRC Clinical Trials Unit, London, UK. 3. Centre for Statistical Methodology, London School of Hygiene and Tropical Medicine, London, UK. 4. Royal Victoria Infirmary, Newcastle upon Tyne, UK. 5. Translational Gastroenterology Unit, Nuffield Department of Medicine, John Radcliffe Hospital, University of Oxford, Oxford, UK. 6. NHS Blood and Transplant Unit, John Radcliffe Hospital, Oxford,UK. 7. Western General Hospital, Edinburgh, UK. 8. Division of Epidemiology and Public Health & Nottingham Digestive Disease Centre University of Nottingham, Nottingham, UK.
Abstract
OBJECTIVES: Previous studies have found higher mortality rates among inpatients (IPs) compared with new admissions (outpatients, OPs) with acute upper gastrointestinal bleeding (AUGIB), but no studies have investigated the cause for this. The objective of this study was to determine whether the difference in outcomes between IPs and OPs with AUGIB can be explained by differences in baseline characteristics, bleeding severity, or processes of care. METHODS: Data were collected from 6,657 presentations with all-cause AUGIB from 212 UK hospitals as part of a nationwide audit. RESULTS: IPs were older (77 vs. 65 years, P<0.001), had greater comorbidity, and presented with more severe bleeding. There was no difference in median time to endoscopy (24 vs. 24 h, P=0.67) or receipt of endotherapy (19% vs. 17%, P=0.29). IPs had an odds of mortality 4.8 times that of OPs (26% vs. 7%; odds ratio (OR) 4.8, 95% confidence interval (CI) 3.9-5.8); after adjusting for baseline characteristics, this fell by 24% to 3.3 (95% CI 3.2-4.9) and after adjusting for bleeding severity alone to 4.0 (95% CI 3.2-4.9); adjusting for care processes had minimal effect. IPs had more than a twofold increased odds of rebleeding (20% vs. 12%; OR 2.1, 95% CI 1.7-2.5); adjusting for both baseline characteristics and severity of bleeding reduced this by 50% (OR 1.4, 95% CI 1.3-2.4), but process of care had no additional impact. CONCLUSIONS: IPs present with both higher baseline risks and more severe bleeding. These differences in baseline characteristics explain some but not all of the greater mortality of IPs with AUGIB.
OBJECTIVES: Previous studies have found higher mortality rates among inpatients (IPs) compared with new admissions (outpatients, OPs) with acute upper gastrointestinal bleeding (AUGIB), but no studies have investigated the cause for this. The objective of this study was to determine whether the difference in outcomes between IPs and OPs with AUGIB can be explained by differences in baseline characteristics, bleeding severity, or processes of care. METHODS: Data were collected from 6,657 presentations with all-cause AUGIB from 212 UK hospitals as part of a nationwide audit. RESULTS: IPs were older (77 vs. 65 years, P<0.001), had greater comorbidity, and presented with more severe bleeding. There was no difference in median time to endoscopy (24 vs. 24 h, P=0.67) or receipt of endotherapy (19% vs. 17%, P=0.29). IPs had an odds of mortality 4.8 times that of OPs (26% vs. 7%; odds ratio (OR) 4.8, 95% confidence interval (CI) 3.9-5.8); after adjusting for baseline characteristics, this fell by 24% to 3.3 (95% CI 3.2-4.9) and after adjusting for bleeding severity alone to 4.0 (95% CI 3.2-4.9); adjusting for care processes had minimal effect. IPs had more than a twofold increased odds of rebleeding (20% vs. 12%; OR 2.1, 95% CI 1.7-2.5); adjusting for both baseline characteristics and severity of bleeding reduced this by 50% (OR 1.4, 95% CI 1.3-2.4), but process of care had no additional impact. CONCLUSIONS: IPs present with both higher baseline risks and more severe bleeding. These differences in baseline characteristics explain some but not all of the greater mortality of IPs with AUGIB.
Authors: Vijaya L Rao; Nina Gupta; Eric Swei; Thomas Wagner; Andrew Aronsohn; K Gautham Reddy; Neil Sengupta Journal: Gastroenterol Rep (Oxf) Date: 2020-04-01
Authors: Philip Dunne; Victoria Livie; Aaron McGowan; Wilson Siu; Sardar Chaudhary; Maximillian Groome; Perminder Phull; Andrew Fraser; Allan John Morris; Ian D Penman; Adrian J Stanley Journal: Frontline Gastroenterol Date: 2021-08-25
Authors: Amy Brenner; Adefemi Afolabi; Syed Masroor Ahmad; Monica Arribas; Rizwana Chaudhri; Timothy Coats; Jack Cuzick; Ian Gilmore; Christopher Hawkey; Vipul Jairath; Kiran Javaid; Aasia Kayani; Muttiullah Mutti; Muhammad Arif Nadeem; Haleema Shakur-Still; Simon Stanworth; Andrew Veitch; Ian Roberts Journal: Trials Date: 2019-07-30 Impact factor: 2.279
Authors: Weam El Hajj; Vincent Quentin; Gaelle Boudoux D'Hautefeuille; Helene Vandamme; Chantal Berger; Mohammed Redha Moussaoui; Aliou Berete; Dominique Louvel; Jean Guy Bertolino; Emmanuel Cuillerier; Quentin Thiebault; Yves Arondel; Sylvie Grimbert; Brigitte Le Guillou; Isabelle Borel; Pierre Lahmek; Stéphane Nahon Journal: United European Gastroenterol J Date: 2021-06-08 Impact factor: 4.623